The reiteration of the Sector Perform rating and maintenance of the $13 price target by RBC Capital suggests a neutral outlook on eHealth's stock in the short term. This indicates that the analyst believes the stock is fairly valued at its current price, and there are no immediate catalysts expected to significantly change its valuation.